Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium.
Year: 1999
Type: article
Source: PubMed
Authors: H Shinohara, J J Killion, C D Bucana, S Yano, I J Fidler
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2112651060
